Company intelligence / Profile preview

Menicon

Ownership: Private
Employees: ~1894
Development stage: Other

Overview

Menicon is Japan’s first and largest contact lens manufacturer with a global presence in over eighty countries. The company has expanded into the life sciences sector through its "Menicon Life Science" division, focusing on advanced medical technologies such as assisted reproductive technology devices and nutritional supplements for eye health. Its core business remains the research, development, manufacturing, and sales of contact lenses and related care solutions. Recent innovations include sperm motility selection devices for fertility clinics and lactoferrin-based supplements to support ocular and systemic health. The company also operates a veterinary ophthalmology subsidiary.[1][2][3][4]

Therapeutic areas: OphthalmologyWomen's Health
Modalities: DeviceSmall moleculeProteinCell selection device
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on Menicon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Menicon.